14 insiders reported 49 Form 4 transactions for Aura Biosciences, Inc. (AURA) over the past 18 months (most recent 2026-07-08). Recent activity: Bender Jeremy (Director) Buy 30,000 shares, Kilroy Conor (See Remarks) Buy 14,858 shares, Gibney Anthony S (See Remarks) Sell 12,824 shares, Srivastava Sapna (Director) Buy 15,000 shares, Mattessich Antony C. (Director) Buy 15,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Bender Jeremy | Director | Buy | 30,000 | $0 |
| 2026-07-01 | Kilroy Conor | See Remarks | Buy | 14,858 | $0 |
| 2026-06-16 | Gibney Anthony S | See Remarks | Sell | 12,824 | $82,330 |
| 2026-06-15 | Srivastava Sapna | Director | Buy | 15,000 | $0 |
| 2026-06-15 | Mattessich Antony C. | Director | Buy | 15,000 | $0 |
| 2026-06-15 | Johnson David Michael | Director | Buy | 15,000 | $0 |
| 2026-06-15 | Bitetti Teresa Marie | Director | Buy | 15,000 | $0 |
| 2026-05-19 | Holles Natalie C. | See Remarks | Buy | 600,118 | $0 |
| 2026-05-19 | Holles Natalie C. | See Remarks | Buy | 553,844 | $0 |
| 2026-05-11 | Matrix Capital Management Company, LP | 10% Owner | Sell | 6.9M | $39.0M |
| 2026-05-11 | GOEL DAVID E. | 10% Owner | Sell | 6.9M | $39.0M |
| 2026-04-16 | Kilroy Conor | See Remarks | Sell | 11,738 | $82,401 |
| 2026-03-03 | Gibney Anthony S | See Remarks | Buy | 71,245 | $0 |
| 2026-03-03 | Plavsic Mark | Chief Technology Officer | Buy | 62,339 | $0 |
| 2026-03-03 | Kilroy Conor | See Remarks | Buy | 62,339 | $0 |
| 2026-03-03 | Elazzouzi Amy | Senior Vice President, Finance | Buy | 44,528 | $0 |
| 2026-03-03 | de los Pinos Elisabet | See Remarks | Buy | 166,000 | $0 |
| 2026-03-03 | Hopkins Janet Jill | Chief Medical Officer | Buy | 89,056 | $0 |
| 2026-02-17 | Kilroy Conor | See Remarks | Sell | 12,079 | $60,999 |
| 2026-02-17 | Plavsic Mark | Chief Technology Officer | Sell | 15,890 | $80,244 |
| 2026-02-17 | Elazzouzi Amy | Senior Vice President, Finance | Sell | 8,549 | $43,258 |
| 2026-02-17 | de los Pinos Elisabet | See Remarks | Sell | 47,648 | $241,099 |
| 2026-02-17 | Hopkins Janet Jill | Chief Medical Officer | Sell | 20,401 | $103,229 |
| 2026-01-20 | Elazzouzi Amy | Senior Vice President, Finance | Sell | 1,581 | $7,684 |
| 2026-01-20 | de los Pinos Elisabet | See Remarks | Sell | 16,928 | $82,270 |
Source: SEC Form 4 filings · as of 2026-07-08